| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |